Cargando…
A Study of Super Refractory Status Epilepticus from India
BACKGROUND: Super refractory status epilepticus (SRSE) is an important and recently recognized neurological emergency. PURPOSE: In view of paucity of studies on SRSE, we report the frequency, etiology and outcome of SRSE. METHODS: In a hospital-based observational study during 2013 to 2016, consecut...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712310/ https://www.ncbi.nlm.nih.gov/pubmed/29234303 http://dx.doi.org/10.3389/fneur.2017.00636 |
_version_ | 1783283198251237376 |
---|---|
author | Misra, Usha K. Kalita, Jayantee Dubey, Deepanshu |
author_facet | Misra, Usha K. Kalita, Jayantee Dubey, Deepanshu |
author_sort | Misra, Usha K. |
collection | PubMed |
description | BACKGROUND: Super refractory status epilepticus (SRSE) is an important and recently recognized neurological emergency. PURPOSE: In view of paucity of studies on SRSE, we report the frequency, etiology and outcome of SRSE. METHODS: In a hospital-based observational study during 2013 to 2016, consecutive patients with SRSE [persistence of status epilepticus (SE) for 24 h or more, or recurrence of SE on weaning of intravenous anesthetic] were included. The demographic, clinical, and laboratory data were obtained and the severity of SE was defined using Status Epilepticus Severity Score (STESS). The outcome was defined as control of SE, hospital death, and functional status at the time of discharge. RESULTS: Fourteen (13%) patients developed SRSE. Their median age was 27.5 (2–70) years and four were below 18 years of age. The etiology of SRSE was metabolic encephalopathy and encephalitis in five patients each, cerebral venous sinus thrombosis in one and miscellaneous disorders in three patients. Six (43%) patients died. The patients with SRSE had higher admission STESS (p = 0.04), and longer intensive care unit (p < 0.01) and hospital (p = 0.004) stay compared to non-SRSE group. The patients with treatable etiology had better outcome. CONCLUSION: SRSE occurred in 13% patients with SE and 43% of them died. The SRSE patients with treatable etiology had a better outcome. |
format | Online Article Text |
id | pubmed-5712310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57123102017-12-11 A Study of Super Refractory Status Epilepticus from India Misra, Usha K. Kalita, Jayantee Dubey, Deepanshu Front Neurol Neuroscience BACKGROUND: Super refractory status epilepticus (SRSE) is an important and recently recognized neurological emergency. PURPOSE: In view of paucity of studies on SRSE, we report the frequency, etiology and outcome of SRSE. METHODS: In a hospital-based observational study during 2013 to 2016, consecutive patients with SRSE [persistence of status epilepticus (SE) for 24 h or more, or recurrence of SE on weaning of intravenous anesthetic] were included. The demographic, clinical, and laboratory data were obtained and the severity of SE was defined using Status Epilepticus Severity Score (STESS). The outcome was defined as control of SE, hospital death, and functional status at the time of discharge. RESULTS: Fourteen (13%) patients developed SRSE. Their median age was 27.5 (2–70) years and four were below 18 years of age. The etiology of SRSE was metabolic encephalopathy and encephalitis in five patients each, cerebral venous sinus thrombosis in one and miscellaneous disorders in three patients. Six (43%) patients died. The patients with SRSE had higher admission STESS (p = 0.04), and longer intensive care unit (p < 0.01) and hospital (p = 0.004) stay compared to non-SRSE group. The patients with treatable etiology had better outcome. CONCLUSION: SRSE occurred in 13% patients with SE and 43% of them died. The SRSE patients with treatable etiology had a better outcome. Frontiers Media S.A. 2017-11-28 /pmc/articles/PMC5712310/ /pubmed/29234303 http://dx.doi.org/10.3389/fneur.2017.00636 Text en Copyright © 2017 Misra, Kalita and Dubey. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Misra, Usha K. Kalita, Jayantee Dubey, Deepanshu A Study of Super Refractory Status Epilepticus from India |
title | A Study of Super Refractory Status Epilepticus from India |
title_full | A Study of Super Refractory Status Epilepticus from India |
title_fullStr | A Study of Super Refractory Status Epilepticus from India |
title_full_unstemmed | A Study of Super Refractory Status Epilepticus from India |
title_short | A Study of Super Refractory Status Epilepticus from India |
title_sort | study of super refractory status epilepticus from india |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712310/ https://www.ncbi.nlm.nih.gov/pubmed/29234303 http://dx.doi.org/10.3389/fneur.2017.00636 |
work_keys_str_mv | AT misraushak astudyofsuperrefractorystatusepilepticusfromindia AT kalitajayantee astudyofsuperrefractorystatusepilepticusfromindia AT dubeydeepanshu astudyofsuperrefractorystatusepilepticusfromindia AT misraushak studyofsuperrefractorystatusepilepticusfromindia AT kalitajayantee studyofsuperrefractorystatusepilepticusfromindia AT dubeydeepanshu studyofsuperrefractorystatusepilepticusfromindia |